2 Penny Stocks That Wall Street Predicts Will Soar 306% to 1,183% in 2025 Both penny stocks are a 'strong buy' on Wall Street. Barchart · Nov 25, 2024
21,000 fish died in catastrophic UC Davis lab mishap. Some were endangered species Researchers discovered Aug. 9 that 21,000 fish had died in their enclosures at UC Davis’ Center For Aquatic Biology and Aquaculture — a mass die-off that appears to have been caused by chlorine exposure. About 100 fish — mostly tilapia — survived. Tribune News Service · Aug 18, 2022
21,000 fish die in ‘catastrophic failure’ at UC Davis facility. Here’s the suspected cause An estimated 21,000 fish died at the U.C. Davis Center for Aquatic Biology and Aquaculture in what the university described as a “catastrophic failure.” Tribune News Service · Aug 11, 2022
ASI Act protecting monuments to be amended for flexibility, people-friendliness A subcommittee is to be formed to look into amending The Ancient Monuments and Archaeological Sites and Remains Act, 1958. The Hindu · Jun 14, 2022
Why Did Mizuho Cut Price Target On This CAR-T Stock, But Remain Bullish Mizuho met Cabaletta Bio Inc (NASDAQ: CABA) management team after last week's data release at ASGCT. Benzinga · May 25, 2022
Govt. reconstitutes Central Advisory Board on Archaeology CABA is revised for a period of three years The Hindu · May 20, 2022
Cabaletta Bio's Updated Interim DSG3-CAART Data Fails To Cheer Investors Cabaletta Bio Inc (NASDAQ:CABA) presented updated data from the DesCAARTes trial, evaluating DSG3-CAART in adults with mucosal-dominant pemphigus vulgaris (mPV), a blistering skin disease that affects mucous membranes. No dose-limiting toxicities were observed within three months of DSG3-CAART infusion through cohort A4 (2.5 billion cells). There was a dose-dependent increase in DSG3-CAART persistence… Benzinga · May 18, 2022
Recap: Cabaletta Bio Q4 Earnings Cabaletta Bio (NASDAQ:CABA) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Benzinga · Mar 17, 2022